Kate Gunther: Rimegepant Shows Antiproliferative Effects in Endometriosis Models
Kate Gunther, Doctoral Student at UNSW, shared a post on LinkedIn:
“New publication alert!
It’s no secret that endometriosis research has been chronically underfunded, which has slowed the development of new and especially non-hormonal treatments. This makes drug repurposing a powerful strategy, allowing us to rapidly evaluate safe, existing medicines for therapeutic potential.
Our new study applies this approach to ROR1, a receptor that we found to be consistently upregulated in endometriosis at both the transcript and protein level.
Key Highlights
- Using a drug repurposing platform, we identified candidates predicted to target ROR1.
- Rimegepant, a clinically approved migraine drug with an established safety profile, showed the strongest antiproliferative effect in 12Z endometriotic epithelial cells.
- In patient-derived organoids, rimegepant produced concentration-dependent and patient-specific reductions in viability and organoid size.
Why it matters
This is the first evidence in human-derived endometriosis models supporting rimegepant as a potential non-hormonal therapy. It also demonstrates how repurposing-focused, translational workflows can accelerate progress in an underfunded field.
This work is a testament to collaborative projects which integrate preclinical, clinical and patient perspectives. I’m very grateful to my collaborators Dongli Liu, Gill Stannard, Nikola Bowden, Caroline Ford and those beyond the LinkedIn sphere for their contributions, and the patients who made this work possible.
Read it here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 12, 2026, 17:02Are You Passionate About Patient Safety and Communication in Healthcare? – RCOG
-
Jul 12, 2026, 17:00Christopher Robinson: Ultrasound-Guided HIFU in Early-Onset Twin-Twin Transfusion Syndrome
-
Jul 12, 2026, 16:59Addressing Sexual Violence, A FIGO Committee on Women Facing Crises Consensus Statement – IJGO
-
Jul 12, 2026, 16:57Clinician vs. Embryologist, Same Cycle, Different Windows into Biology – Indore Infertility Clinic and IVF Center
-
Jul 12, 2026, 16:56Marco Zaccaria: Understanding Uterine Fibroids Through Nutrition and Lifestyle!
-
Jul 12, 2026, 16:54Camille Clare: ACOG Begins New Leadership Chapter with Inaugural Board Meeting!
-
Jul 12, 2026, 16:53Sandro Esteves: Scientific Exchange and Innovation in Male Fertility at London’s IVF Masterclass
-
Jul 12, 2026, 16:51George Woodhead: Sharing Our Work on Cryotransport of Vitrified Donor Oocytes at ESHRE!
-
Jul 12, 2026, 16:49How ESHRE 2026 Is Shaping the Future of Reproductive Medicine? – Umana Fertility